Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer.

Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Area Under Curve
Carboplatin
Carcinoma, Non-Small-Cell Lung
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Prospective Studies
Survival Rate
Taxoids
Treatment Outcome
Tumor Burden

authors with profiles

Jessica Donington